Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

419 ARTÍCULOS , VIENDO DEL 391 AL 405

Comparisons of vesicular monoamine transporter type 2 signals in Parkinson's disease and parkinsonism secondary to carbon monoxide poisoning

Hsiao IT, Chang YT, Weng YH, Hsu SW, Lin KJ, Lu CS, Chang CC.

Neurotoxicology. 2022 Jan;88:178-186. doi: 10.1016/j.neuro.2021.11.004. Epub 2021 Nov 10.

Acute Parkinsonism in a Patient with Spinal Cord Injury: A Case Report

Perrotta F, Perrini MP, Cantatore LP.

J Neurol Surg A Cent Eur Neurosurg. 2022 May;83(3):298-300. doi: 10.1055/s-0041-1724108. Epub 2021 Nov 17.

Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis

Lu S, Jiang HY, Shi YD.

Acta Neurol Scand. 2022 Apr;145(4):442-448. doi: 10.1111/ane.13570. Epub 2021 Dec 15.

A multimodal Parkinson quantification by fusing eye and gait motion patterns, using covariance descriptors, from non-invasive computer vision

Archila J, Manzanera A, Martínez F.

Comput Methods Programs Biomed. 2022 Mar;215:106607. doi: 10.1016/j.cmpb.2021.106607. Epub 2021 Dec 30.

Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study

Nomoto M, Ishida T, Koebis M, Kamei T, Suzuki I, Hattori N, Tsuboi Y.

J Neurol Sci. 2022 Mar 15;434:120083. doi: 10.1016/j.jns.2021.120083. Epub 2021 Dec 11.

Palato-Lingual Tremor in a Child With Juvenile-Onset Alexander Disease

Almudhry M, Alotaibi M, Mir A.

Pediatr Neurol. 2022 Jan;126:1-2. doi: 10.1016/j.pediatrneurol.2021.09.021. Epub 2021 Oct 6.

Socio-demographic characteristics and psychopathological assessment in a sample of 13 paediatric patients with functional neurological disorders: A preliminary report

Paleari V, Nisticò V, Nardocci N, Canevini MP, Priori A, Gambini O, Zorzi G, Demartini B.

Clin Child Psychol Psychiatry. 2022 Apr;27(2):492-503. doi: 10.1177/13591045211055084. Epub 2021 Nov 6.

New-onset Oscillopsia in a Patient With a History of Pontine Stroke

Kabanovski A, Donaldson L, Margolin E.

J Neuroophthalmol. 2022 Jun 1;42(2):e520-e522. doi: 10.1097/WNO.0000000000001461. Epub 2021 Dec 28.

Synaptic effects of ethanol on striatal circuitry: therapeutic implications for dystonia

Imbriani P, Sciamanna G, El Atiallah I, Cerri S, Hess EJ, Pisani A.

FEBS J. 2022 Oct;289(19):5834-5849. doi: 10.1111/febs.16106. Epub 2021 Jul 16.

Editorial "Parkinsonism across the spectrum of movement disorders and beyond"

Jankovic J, Truong DD, Bologna M.

J Neurol Sci. 2022 Feb 15;433:120013. doi: 10.1016/j.jns.2021.120013. Epub 2021 Oct 1.

Prevalence of distinct types of hardware failures related to deep brain stimulation

Cabral AM, Pereira AA, Vieira MF, Pessôa BL, de Oliveira Andrade A.

Neurosurg Rev. 2022 Apr;45(2):1123-1134. doi: 10.1007/s10143-021-01673-4. Epub 2021 Oct 19.

Deep Brain Stimulation for Cockayne Syndrome-Associated Movement Disorder

Domino JS, Gelineau-Morel R, Kaufman C.

J Mov Disord. 2022 Jan;15(1):62-65. doi: 10.14802/jmd.21005. Epub 2021 Nov 3.

Therapeutic application of rTMS in neurodegenerative and movement disorders: A review

Pateraki G, Anargyros K, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Ziogka P, Sgantzos M, Folia V, Peristeri E, Dardiotis E.

J Electromyogr Kinesiol. 2022 Feb;62:102622. doi: 10.1016/j.jelekin.2021.102622. Epub 2021 Nov 26.

Sporadic Creutzfeldt-Jakob disease

Salehi P, Clark M, Pinzon J, Patil A.

Am J Emerg Med. 2022 Feb;52:267.e1-267.e3. doi: 10.1016/j.ajem.2021.07.038. Epub 2021 Jul 22.

Mercury and Movement Disorders: The Toxic Legacy Continues

Ganguly J, Kulshreshtha D, Jog M.

Can J Neurol Sci. 2022 Jul;49(4):493-501. doi: 10.1017/cjn.2021.146. Epub 2021 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias